The rate of myocardial infarction events among patients with age-related macular degeneration: a population-based

Shani Golan1, Varda Shalev, Michaela Goldstein

  • 1Department of Ophthalmology, Tel Aviv Sourasky Medical Center, 6 Weizman Street, Tel Aviv, 64239, Israel. shanigol2@walla.com

Insights

This study found no increased risk of myocardial infarction (MI) in patients with age-related macular degeneration (AMD). Despite shared risk factors, AMD did not elevate MI risk in this large health maintenance organization cohort.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Epidemiology

Background:

  • Age-related macular degeneration (AMD) and myocardial infarction (MI) share common risk factors.
  • Understanding the potential association between AMD and cardiovascular events is crucial for comprehensive patient care.

Purpose of the Study:

  • To investigate the association between age-related macular degeneration (AMD) and the risk of myocardial infarction (MI).
  • To determine if AMD diagnosis increases the likelihood of experiencing an MI in a large healthcare setting.

Main Methods:

  • Retrospective cohort study at Maccabi Healthcare Services.
  • Included 6,546 patients with AMD and 61,672 matched controls aged ≥65 years.
  • Followed participants to assess incident myocardial infarction events using Cox proportional hazard models.

Main Results:

  • The incidence of MI was 5.1 per 1,000 person-years in the AMD group and 4.2 per 1,000 person-years in the non-AMD group.
  • The age- and gender-adjusted hazard ratio for MI in AMD patients was 1.01 (95% CI: 0.85-1.20).
  • The fully adjusted hazard ratio for MI associated with AMD was 1.03 (95% CI: 0.87-1.22).

Conclusions:

  • No statistically significant increased risk of myocardial infarction was observed in patients with age-related macular degeneration.
  • Shared risk factors do not translate to a higher incidence of MI among AMD patients.
  • Findings suggest AMD is not an independent risk factor for MI.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...